Fu X, Xu Y, Han X, Lin X, Wang J, Li G
Biol Proced Online. 2025; 27(1):4.
PMID: 39893380
PMC: 11786495.
DOI: 10.1186/s12575-025-00266-5.
Sokoli L, Takac P, Budovska M, Michalkova R, Kello M, Nosalova N
Biomolecules. 2025; 15(1).
PMID: 39858466
PMC: 11762530.
DOI: 10.3390/biom15010072.
Oriakhi K, Erharuyi O, Orumwensodia K, Essien E, Falodun A, Uadia P
Toxicol Rep. 2024; 13:101833.
PMID: 39717850
PMC: 11665704.
DOI: 10.1016/j.toxrep.2024.101833.
Santos T, Pereira Q, Fortunato I, Oliveira F, Alvarez M, Ribeiro M
Nutrients. 2024; 16(21).
PMID: 39519454
PMC: 11547493.
DOI: 10.3390/nu16213621.
Yan J, Yang A, Tu S
Front Oncol. 2024; 14:1445978.
PMID: 39502314
PMC: 11534658.
DOI: 10.3389/fonc.2024.1445978.
The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis.
Lei Z, Teng Q, Koya J, Liu Y, Chen Z, Zeng L
Front Immunol. 2024; 15:1417201.
PMID: 39403386
PMC: 11471544.
DOI: 10.3389/fimmu.2024.1417201.
TLR3 activation mediates partial epithelial-to-mesenchymal transition in human keratinocytes.
Schneider A, Feehan R, Sennett M, Wills C, Garner C, Cong Z
Life Sci Alliance. 2024; 7(12).
PMID: 39348939
PMC: 11443013.
DOI: 10.26508/lsa.202402777.
A Boolean model explains phenotypic plasticity changes underlying hepatic cancer stem cells emergence.
Hernandez-Magana A, Bensussen A, Martinez-Garcia J, Alvarez-Buylla E
NPJ Syst Biol Appl. 2024; 10(1):99.
PMID: 39223160
PMC: 11369243.
DOI: 10.1038/s41540-024-00422-9.
Engineering principles for rationally design therapeutic strategies against hepatocellular carcinoma.
Hernandez-Magana A, Bensussen A, Martinez-Garcia J, Alvarez-Buylla E
Front Mol Biosci. 2024; 11:1404319.
PMID: 38939509
PMC: 11208463.
DOI: 10.3389/fmolb.2024.1404319.
The Role of Mesenchymal Reprogramming in Malignant Clonal Evolution and Intra-Tumoral Heterogeneity in Glioblastoma.
Wu Q, Berglund A, Macaulay R, Etame A
Cells. 2024; 13(11.
PMID: 38891074
PMC: 11171993.
DOI: 10.3390/cells13110942.
Effects of Red Sorghum-Derived Deoxyanthocyanidins and Their O-β-D-Glucosides on E-Cadherin Promoter Activity in PC-3 Prostate Cancer Cells.
Mora N, Rosa M, Touaibia M, Martin L
Molecules. 2024; 29(8).
PMID: 38675711
PMC: 11054106.
DOI: 10.3390/molecules29081891.
The NFκB Signaling Pathway Is Involved in the Pathophysiological Process of Preeclampsia.
Li Y, Zhu Q, He R, Du J, Qin X, Li Y
Geburtshilfe Frauenheilkd. 2024; 84(4):334-345.
PMID: 38618576
PMC: 11006561.
DOI: 10.1055/a-2273-6318.
NF-κB signaling activation and roles in thyroid cancers: implication of MAP3K14/NIK.
Cormier F, Housni S, Dumont F, Villard M, Cochand-Priollet B, Mercier-Nome F
Oncogenesis. 2023; 12(1):55.
PMID: 37973791
PMC: 10654696.
DOI: 10.1038/s41389-023-00496-w.
Particulate matter promotes the epithelial to mesenchymal transition in human lung epithelial cells via the ROS pathway.
Zhang J, Xu X, Liang Y, Wu X, Qian Z, Zhang L
Am J Transl Res. 2023; 15(8):5159-5167.
PMID: 37692935
PMC: 10492054.
Loss of EGF receptor polarity enables homeostatic imbalance in epithelial-cell models.
Carlin C, Ngalula S
Mol Biol Cell. 2023; 34(12):ar116.
PMID: 37647145
PMC: 10846618.
DOI: 10.1091/mbc.E23-04-0133.
Baicalin alleviates silica-induced lung inflammation and fibrosis by inhibiting TLR4/NF-?B pathway in rats.
Zhang Y, Liu F, Jia Q, Zheng L, Tang Q, Sai L
Physiol Res. 2023; 72(2):221-233.
PMID: 37159856
PMC: 10226396.
6-Shogaol Inhibits the Cell Migration of Colon Cancer by Suppressing the EMT Process Through the IKKβ/NF-κB/Snail Pathway.
Chen M, Tong C, Wu Q, Zhong Z, He Q, Zeng L
Integr Cancer Ther. 2023; 22:15347354231172732.
PMID: 37157810
PMC: 10185977.
DOI: 10.1177/15347354231172732.
Boolean modeling of mechanosensitive epithelial to mesenchymal transition and its reversal.
Sullivan E, Harris M, Bhatnagar A, Guberman E, Zonfa I, Regan E
iScience. 2023; 26(4):106321.
PMID: 36968076
PMC: 10030917.
DOI: 10.1016/j.isci.2023.106321.
Attenuation of Inflammatory Responses in Breast and Ovarian Cancer Cells by a Novel Chalcone Derivative and Its Increased Potency by Curcumin.
Nourbakhsh M, Noori S, Aminzade Z, Bayanati M, Alemi M, Zarghi A
Mediators Inflamm. 2023; 2023:5156320.
PMID: 36687217
PMC: 9851785.
DOI: 10.1155/2023/5156320.
Phenotype Switching and the Melanoma Microenvironment; Impact on Immunotherapy and Drug Resistance.
Hossain S, Eccles M
Int J Mol Sci. 2023; 24(2).
PMID: 36675114
PMC: 9864717.
DOI: 10.3390/ijms24021601.